FindTrial
Sign In

Removal of inflammatory factors by hemoperfusion in cardiopulmonary bypass of patients with type A aortic dissection

Removal of inflammatory factors by hemoperfusion in cardiopulmonary bypass of patients with type A aortic dissection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034431
Enrollment
Unknown
Registered
2020-07-05
Start date
2020-07-15
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Standford type A aortic dissection

Interventions

experimental group:Use the disposable hemoperfutor(HA 380) during the operation
Control group:Not use the disposable hemoperfutor (HA 380) during the operation

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged>18 years; 2. Patients received the surgery under CPB and DHCA.

Exclusion criteria

Exclusion criteria: 1. Patients participating in other intervention trials; 2. Patients and their families refused to participate in the trial.

Design outcomes

Primary

MeasureTime frame
inflammatory cytokines;—

Countries

China

Contacts

Public ContactZhong Wu

West China Hospital, Sichuan University

wuzhong71@scu.edu.cn+86 18980606048

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026